Login

Union Square Ventures is a venture capital firm|Brad Burnham,Partner,Union Square Ventures 00:10:00

Share On Facebook Share On Twitter

He started working in information technology with AT&T in 1979

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Focus exclusively on founders starting companies that are pre-traction|Anamitra Banerji,Managing Director, Afore Capital
00:10:00
Nordic Nickel CEO Todd Ross Discusses Pulu Project and Growth Plans
00:10:00
RNC Updates on High-Grade Gold Discoveries and Key Project Developments
00:10:00
Your financial well-being is our first priority|Nancy Mullally CEO, CFO, Chairman of the Board, Alamo capital
00:10:00
Chris Flower discusses his passion for chess and its parallels with business prowess | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
Joby's Air Taxi Approval Sparks Share Surge | JoeBen Bevirt - CEO of Joby Aviation , Inc.
00:10:00
Miles Roberts Visits North America | Miles W. Roberts - CEO of DS Smith
00:10:00
Presentation by Rainbow: An Overview of Current Rare Earth Projects and the Unique Palabora Project
00:00:00
SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities" - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:10:00
Locaweb Faces COVID-19 Challenges Post-IPO, Plans Major Acquisition Investments | Fernando Cirne, CEO , Locaweb Serviços De Internet SA.
00:10:00
Building a Greener Future: Insights from the HKGFA Webinar on Hong Kong's Sustainable Infrastructure Strategy | HKGFA Panel Discussion
00:10:00
Guggenheim Partners has a track record of delivering innovative investment and advisory solutions|Alan Schwartz,CEO, Guggenheim Partners

© 2017 - Neuhu+